Angiotensin‐II receptors: new targets for antihypertensive therapy

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Clinical Cardiology

• Publication date

  1997-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/CLC.4960200103PMID 8994730PMCID PMC6655881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of blood pressure by the type 1A angiotensin II receptor gene.

  1995cited by this paper
• Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension.

  1995cited by this paper
• Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors

  1995cited by this paper
• A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension.

  1995cited by this paper
• Genetic control of blood pressure and the angiotensinogen locus.

  1995cited by this paper
• Blood pressure effects of the angiotensin II receptor blocker, losartan.

  1995cited by this paper
• Differential expression of angiotensin receptor 1A and 1B in mouse.

  1994cited by this paper
• Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis.

  1994cited by this paper
• Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study.

  1994cited by this paper
• Effects of modulators of the renin—angiotensin—aldosterone system on cough

  1994cited by this paper
• Angiotensin II receptors and angiotensin II receptor antagonists.

  1993cited by this paper
• Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition.

  1993cited by this paper
• Molecular basis of human hypertension: role of angiotensinogen.

  1992cited by this paper
• Molecular cloning of AT1 angiotensin receptors.

  1992cited by this paper
• Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat.

  1991cited by this paper
• Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats

  1991cited by this paper
• Abnormal Renal Function and Autoregulation in Essential Hypertension

  1991cited by this paper
• Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications

  1990cited by this paper
• Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation.

  1986cited by this paper

• Gut microbiota and their effects on atherosclerosis, platelet function, and hypertension

  2021cites this paper
• Fabrication of PCL/keratin composite scaffolds for vascular tissue engineering with catalytic generation of nitric oxide potential.

  2020cites this paper
• Endothelial Dysfunction, a Marker of Atherosclerosis, Is Independent of Metabolic Syndrome in NAFLD Patients

  2020cites this paper
• Effects of Puerarin on Clinical Parameters, Vascular Endothelial Function, and Inflammatory Factors in Patients with Coronary Artery Disease

  2019cites this paper
• Connexin37‐Dependent Mechanisms Selectively Contribute to Modulate Angiotensin II‐Mediated Hypertension

  2019cites this paper
• Histological verification of atherosclerosis due to bends and bifurcations in carotid arteries predicted by hemodynamic model

  2018cites this paper
• The Effects of Flavonoids on Cardiovascular Health: A Review of Human Intervention Trials and Implications for Cerebrovascular Function

  2018cites this paper
• Physiologically-based pharmacokinetic predictions of intestinal BCRP-mediated drug interactions of rosuvastatin in Koreans

  2018cites this paper
• NO production and potassium channels activation induced by Crotalus durissus cascavella underlie mesenteric artery relaxation

  2017cites this paper
• FLOW MEDIATED DILATION AND CAROTID INTIMA MEDIA THICKNESS IN PATIENTS WITH CHRONIC GASTRITIS ASSOCIATED WITH HELICOBACTER PYLORI INFECTION.

  2017cites this paper
• Retracted: Physiologically based pharmacokinetic predictions of intestinal BCRP‐mediated effect of telmisartan on the pharmacokinetics of rosuvastatin in humans

  2017cites this paper
• Risk factors and angiographic profile of coronary slow flow (CSF) phenomenon in North Indian population: An observational study

  2017cites this paper
• Common carotid artery diameter responds to intravenous volume expansion: an ultrasound observation

  2016cites this paper
• Intact endothelial and contractile function of coronary artery after 8 hours of heart preservation

  2016cites this paper
• Chemerin as an independent predictor of cardiovascular event risk

  2016cites this paper
• Hot flashes: emerging cardiovascular risk factors in recent and late postmenopause and their association with higher blood pressure

  2016cites this paper
• Pulse Wave Velocity, Intima Media Thickness, and Flow-mediated Dilatation in Patients with Normotensive Normoglycemic Inflammatory Bowel Disease

  2015cites this paper
• Expression of Sphingosine-1-phosphate (S1P) on the cerebral vasospasm after subarachnoid hemorrhage in rabbits.

  2015cites this paper
• Cellular and molecular biology of aging endothelial cells.

  2015cites this paper
• Rapid in situ endothelialization of a small diameter vascular graft with catalytic nitric oxide generation and promoted endothelial cell adhesion.

  2015cites this paper
• Hydroxybutyl Chitosan Polymer-Mediated CD133 Antibody Coating of Metallic Stents to Reduce Restenosis in a Porcine Model of Atherosclerosis

  2015cites this paper
• Pretreatment with β-Boswellic Acid Improves Blood Stasis Induced Endothelial Dysfunction: Role of eNOS Activation

  2015cites this paper
• The Endothelium as a Target for the Treatment of Heart Failure

  2015cites this paper
• Procyanidin C1 Causes Vasorelaxation Through Activation of the Endothelial NO/cGMP Pathway in Thoracic Aortic Rings

  2014cites this paper
• You're only as old as your arteries: translational strategies for preserving vascular endothelial function with aging.

  2014cites this paper
• Inflammatory biomarkers for predicting cardiovascular disease.

  2013cites this paper
• Assessment of endothelial dysfunction in patients with impaired glucose tolerance during a cold pressor test

  2013cites this paper
• Barrier protective effects of rutin in LPS-induced inflammation in vitro and in vivo.

  2012cites this paper
• Preventing a Cardiovascular Disease Epidemic among Indigenous Populations through Lifestyle Changes

  2012cites this paper
• A procyanidin trimer, C1, promotes NO production in rat aortic endothelial cells via both hyperpolarization and PI3K/Akt pathways.

  2012cites this paper
• The role of renin angiotensin system intervention in stage B heart failure.

  2012cites this paper
• Site-directed immobilization of antibodies onto blood contacting grafts for enhanced endothelial cell adhesion and proliferation

  2011cites this paper
• Importance of high-density lipoprotein-cholesterol (HDL-C) levels to the incidence of cardiovascular disease (CVD) in the elderly.

  2011cites this paper
• n-3 PUFA prevent metabolic disturbances associated with obesity and improve endothelial function in golden Syrian hamsters fed with a high-fat diet

  2011cites this paper
• Immunohistochemical expression of von Willebrand factor in the preeclamptic placenta

  2011cites this paper
• In situ endothelialization of intravascular stents from progenitor stem cells coated with nanocomposite and functionalized biomolecules

  2011cites this paper
• Improved hemocompatibility and endothelialization of vascular grafts by covalent immobilization of sulfated silk fibroin on poly(lactic-co-glycolic acid) scaffolds.

  2011cites this paper
• The vasoprotective effect of JP05 through the activation of PI3K/Akt-dependent eNOS and MEK/ERK pathways in brain endothelial cells.

  2010cites this paper
• Age-related change in endothelial and microvessel function and therapeutic consequences

  2010cites this paper
• Pleiotropic effects of ezetimibe: do they really exist?

  2010cites this paper
• Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension

  2009cites this paper
• Tubular nanofiber scaffolds for tissue engineered small-diameter vascular grafts.

  2009cites this paper
• Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice.

  2009cites this paper
• Development of mussel adhesive polypeptide mimics coating for in-situ inducing re-endothelialization of intravascular stent devices.

  2009cites this paper
• Combinatorial coating of adhesive polypeptide and anti-CD34 antibody for improved endothelial cell adhesion and proliferation

  2009cites this paper
• Total occlusion of the infarct-related coronary artery correlates with brachial artery flow-mediated dilation in patients with ST-elevation myocardial infarction

  2009cites this paper
• The Peritoneal Microcirculation in Peritoneal Dialysis

  2009cites this paper
• Flow-Mediated Vasodilation as a Diagnostic Modality for Vascular Failure

  2008cites this paper
• Urocortin: a beneficial or detrimental agent to endothelium?

  2008cites this paper
• Effect of Valsartan on Blood Pressure and Urinary Albumin Excretion in Hypertensive Type 2 Diabetic Patients: An Open-Label, Multicenter Study

  2008cites this paper
• Effect of bis (maltolato) oxovanadium (BMOV) in uric acid and sodium arsenite-induced vascular endothelial dysfunction in rats.

  2008cites this paper
• LESSONS FROM ONTARGET

  2008cites this paper
• Statin Therapy for Vascular Failure

  2007cites this paper
• Experimental Models for Vascular Endothelial Dysfunction

  2007cites this paper
• Statin therapy in South-Asian patients: clinical implications beyond lipid lowering?

  2007cites this paper
• Layer-by-layer assembly of biomacromolecules on poly(ethylene terephthalate) films and fiber fabrics to promote endothelial cell growth.

  2007cites this paper
• Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.

  2007cites this paper
• Icariin enhances endothelial nitric-oxide synthase expression on human endothelial cells in vitro.

  2007cites this paper
• Aging Reduces Skeletal Blood Flow, Endothelium‐Dependent Vasodilation, and NO Bioavailability in Rats

  2007cites this paper
• Extrinsic Regulation of the Vasculature

  2007cites this paper
• Insulin down‐regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro

  2007cites this paper
• Chapter 81 – Angiotensin II Receptor Blockers

  2007cites this paper
• Regulationsmechanismen des Renin-Angiotensin-Systems im kardiovaskulären System

  2006cites this paper
• Vascular failure: a new clinical entity for vascular disease

  2006cites this paper
• PREDOMINANT CONTRIBUTION OF OATP1B3 TO THE HEPATIC UPTAKE OF TELMISARTAN, AN ANGIOTENSIN II RECEPTOR ANTAGONIST, IN HUMANS

  2006cites this paper
• Laser Doppler perfusion imaging of the radial forearm flap: A clinical study

  2006cites this paper
• Fabrication of collagen-coated biodegradable polymer nanofiber mesh and its potential for endothelial cells growth.

  2005cites this paper
• AIDS-related vasculopathy: evidence for oxidative and inflammatory pathways in murine and human AIDS.

  2005cites this paper
• Oxygen Regulation of Endothelial Cell Phenotypes

  2005cites this paper
• Paradoxical Effects of Iron Chelation on Growth of Vascular Endothelial Cells

  2005cites this paper
• Preparation and characterization of polymeric coatings with combined nitric oxide release and immobilized active heparin.

  2005cites this paper
• Clinical efficacy and safety of telmisartan 80 mg once daily compared with enalapril 20 mg once daily in patients with mild‐to‐moderate hypertension: results of a multicentre study

  2004cites this paper
• Neuronal nitric oxide synthase as a novel anti-atherogenic factor.

  2004cites this paper
• Angiotensin II Receptor Binding in the Locus ceruleus of Spontaneously Hypertensive Rats and Wistar-Kyoto Rats: A Quantitative Autoradiographic Study with References to Hypertension and Cardiac/Testicular Hypertrophy

  2004cites this paper
• Physiological aspects and clinical sequelae of energy deficiency and hypoestrogenism in exercising women.

  2004cites this paper
• Blood oxygen transport and endothelial dysfunction in patients with arterial hypertension

  2004cites this paper
• Wnk1 kinase deficiency lowers blood pressure in mice: A gene-trap screen to identify potential targets for therapeutic intervention

  2003cites this paper
• New definitions in cardiovascular risk management: is it time for angiotensin II receptor blockers to become first-line medication?

  2003cites this paper
• Effects of aspirin on N‐α‐tosyl l‐arginine methyl ester [TAME]‐esterase induced contractions on rat aorta in vitro

  2003cites this paper
• Mechanisms Underlying the Programming of Small Artery Dysfunction: Review of the Model Using Low Protein Diet in Pregnancy in the Rat

  2003cites this paper
• [Telmisartan (micardis) -- an antagonist of angiotensin 2 of type 1 receptors: another antihypertensive drug or something greater?].

  2003cites this paper
• Functional significance of a hereditary adenine insertion variant in the 5'-UTR of the endothelin-1 gene.

  2003cites this paper
• Effects of angiotensin II on vascular endothelial cells: formation of receptor-mediated reactive nitrogen species.

  2003cites this paper
• [Angiotensin1-receptor antagonist losartan. Part I. Basic clinical pharmacology].

  2003cites this paper
• Clinical trials evaluating angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the setting of acute myocardial infarction

  2003cites this paper
• PPOGRESS beyond HOPE and LIFE: The ONTARGET trial programme

  2003cites this paper
• Vascular smooth muscle and nitric oxide synthase

  2002cites this paper
• Treating hypertension in patients with diabetes.

  2002cites this paper
• Flow‐mediated dilatation of the brachial artery in pregnancy at high altitude

  2002cites this paper
• Pathophysiologic and Therapeutic Importance of Tissue ACE: A Consensus Report

  2002cites this paper
• Integrated Coronary Physiology and Pathophysiology

  2002cites this paper
• Angiotensin II subtype 1 receptor blockers and renal function.

  2001cites this paper
• Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study.

  2001cites this paper
• Sex differences and the effects of sex hormones on hemostasis and vascular reactivity.

  2001cites this paper
• Clinical Pharmacology of the Angiotensin Receptor Antagonists

  2001cites this paper
• eNOS and prostanoid enzymes in lungs of newborn piglets with chronic aortopulmonary shunts.

  2001cites this paper
• The comparative pharmacology of angiotensin II receptor antagonists.

  2001cites this paper
• Acute effects of oats and vitamin E on endothelial responses to ingested fat.

  2001cites this paper
• Inhibitory Effect of Telmisartan on the Blood Pressure Response to Angiotensin II Challenge

  2001cites this paper
• The endothelium: Dysfunction and beyond

  2001cites this paper